4-(1H-Pyrazol-1-yl)benzaldehyde → 3-(Quinolin-7-yl)prop-2-enal
Reaction equation
[N:1]1[C:10]2[C:5](=[CH:6][CH:7]=[C:8]([CH:11]=O)[CH:9]=2)[CH:4]=[CH:3][CH:2]=1.N1(C2C=C[C:21]([CH:22]=[O:23])=CC=2)C=CC=N1>>[N:1]1[C:10]2[C:5](=[CH:6][CH:7]=[C:8](/[CH:11]=[CH:21]/[CH:22]=[O:23])[CH:9]=2)[CH:4]=[CH:3][CH:2]=1Participants
3
Procedure
The title compound was prepared by a procedure analogous to Reference Example 30 by substituting 7-quinolinecarboxaldehyde (prepared as described in J. Med. Chem. 1993, 36, 3308) for the 4-(1H-pyrazol-1-yl)-benzaldehyde of Reference Example 30. MS 184 (M+H)+.
Sources & evidence
- ORD record
- ord-9d7e9b68e0194e02a410e0ada0d13c30
- Source dataset
- uspto-grants-2004_11
- Patent number
- US06825170B2
Reaction notes
Loading…